Table 2.
Results of the comprehensive genomic profiling of the metastatic CRC to the left kidney
| Gene | Genomic alteration |
|---|---|
| PDL1 | |
| PDL2 | Amplification (9p24.1 amplicon) |
| JAK2 | |
| KRAS | Amplification |
| CCND2 | Amplification |
| APC | Mutation (V1320 fs*11, R283*) |
| CDK8 | Amplification (equivocal) |
| FGF23 | Amplification |
| FGF6 | Amplification |
| FLT3 | Amplification (equivocal) |
| KDM5A | Amplification |
| TP53 | Mutation (S241 fs*19) |
| CDH1 | Loss in exons 1–2 |
| Additional findings | |
| MSI status | MS-stable |
| TMB | Four mutations/mb |